Literature DB >> 10653130

TGF-beta activates genes identified by differential mRNA display in pancreatic rudiments.

T Battelino1, F Miralles, C Krzisnik, R Scharfmann, P Czernichow.   

Abstract

The effect of TGF-beta on gene activation in embryonic pancreatic rudiments was investigated using differential mRNA display. Several cDNA bands were augmented and some were suppressed in the presence of TGF-beta. Differentially expressed cDNAs were re-amplified, sequenced, and sequences compared to the GeneBank database. Glucagone and brain alpha-tropomyosin cDNAs were identified from the group of augmented cDNAs, and B-carboxypeptidase form the group of suppressed cDNAs. PCR experiments were confirmed with Northern blots. Obtained results are in accordance with immunohistochemical findings and render differential mRNA display a useful technique in identifying differentially expressed genes in embryonic pancreatic rudiments. Several unknown differentially expressed cDNA sequences obtained in our experiments remain to be identified.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10653130

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  3 in total

1.  Role for BRG1 in cell cycle control and tumor suppression.

Authors:  Kristin B Hendricks; Frances Shanahan; Emma Lees
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

2.  One process for pancreatic beta-cell coalescence into islets involves an epithelial-mesenchymal transition.

Authors:  Lori Cole; Miranda Anderson; Parker B Antin; Sean W Limesand
Journal:  J Endocrinol       Date:  2009-07-16       Impact factor: 4.286

3.  ALK1 signalling analysis identifies angiogenesis related genes and reveals disparity between TGF-beta and constitutively active receptor induced gene expression.

Authors:  Andreas Lux; Fiona Salway; Holly K Dressman; Gabriele Kröner-Lux; Mathias Hafner; Philip J R Day; Douglas A Marchuk; John Garland
Journal:  BMC Cardiovasc Disord       Date:  2006-04-04       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.